6-Aminoisoquinoline CAS#23687-26-5 Product Description
6-Aminoisoquinoline is a nitrogen-containing heterocyclic organic compound that represents an important structural class in medicinal chemistry and pharmaceutical research. Nitrogen heterocycles are widely utilized in drug discovery and development because of their diverse chemical properties and potential biological activities. These molecular frameworks are frequently incorporated into pharmaceutical compounds and investigational drug candidates, contributing to the development of a wide range of therapeutic agents. Owing to its heterocyclic structure and potential as a versatile synthetic building block, 6-Aminoisoquinoline is of considerable interest in organic synthesis, medicinal chemistry, and pharmaceutical research and development.
6-Aminoisoquinoline CAS#23687-26-5 Chemical Properties
| Melting point | 211-212 °C(Solv: benzene (71-43-2)) |
| Boiling point | 343.1±15.0 °C(Predicted) |
| Density | 1.210±0.06 g/cm3(Predicted) |
| Storage temp. | Keep in dark place,Inert atmosphere,Room temperature |
| Solubility | DMF (Slightly), DMSO (Sparingly), Methanol (Slightly) |
| Form | solid |
| Pka | 7.10±0.10(Predicted) |
| Color | Light yellow to yellow |
6-Aminoisoquinoline CAS#23687-26-5 Safety Information
| Hazard Codes | Xn |
| Risk Statements | 22-36 |
| Safety Statements | 26 |
| HS Code | 2933499090 |
6-Aminoisoquinoline CAS#23687-26-5 Product Application
Aminoisoquinoline derivatives represent an important class of nitrogen-containing heterocyclic compounds with considerable relevance in organic synthesis and medicinal chemistry. They are frequently employed as versatile synthetic intermediates and structural building blocks in the preparation of various polycyclic nitrogen-containing heteroaromatic compounds. In addition to their synthetic applications, these derivatives have attracted significant attention in pharmaceutical research due to their potential biological activities, particularly their promising properties in anticancer research and the development of novel therapeutic candidates.
